SCHEMBL388334

SCHEMBL388334

COc1cc(S)cc(OC)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.69
CYP1A1 P04798 7/20 0.50
CYP1B1 Q16678 7/20 0.50
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2E1 P05181 2/20 0.44
CYP2C8 P10632 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2A6 P11509 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP4B1 P13584 2/20 0.44
CYP2B6 P20813 2/20 0.44
CYP3A5 P20815 2/20 0.44
CYP2A7 P20853 2/20 0.44
CYP3A7 P24462 2/20 0.44
CYP2F1 P24903 2/20 0.44
CYP2C18 P33260 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2J2 P51589 2/20 0.44
CYP4F2 P78329 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143270 0.97 ALDH1A1 (0.65) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL385242 0.84 ALDH1A1 (0.48) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL2284473 0.83 ALDH1A1 (0.48) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
1,3,5-Trimethoxybenzene SCHEMBL28493 0.83 ALDH1A1 (1.00) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL15211248 0.82 ALDH1A1 (0.46) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL13429884 0.82 ALDH1A1 (0.46) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL3646752 0.82 ALDH1A1 (0.46) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
1,3,5-Trimethoxybenzene SCHEMBL28557531 0.79 ALDH1A1 (0.92) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
1,3,5-Trimethoxybenzene SCHEMBL28740008 0.79 ALDH1A1 (0.92) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
1,3,5-Trimethoxybenzene SCHEMBL28416912 0.79 ALDH1A1 (0.92) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105399672-B The synthetic method of invertibity acetylcholinesterase inhibitor huperzine 昶凡生物科技(上海)有限公司 2019-01-25 CN claimed
US-20150083466-A1 Method For The Functionalisation Of Metal Nanowires And The Production Of Electrodes COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-03-26 US claimed
EP-2734310-A1 METHOD FOR THE FUNCTIONALISATION OF METAL NANOWIRES AND THE PRODUCTION OF ELECTRODES Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2014-05-28 EP claimed
WO-2013014591-A1 METHOD FOR THE FUNCTIONALISATION OF METAL NANOWIRES AND THE PRODUCTION OF ELECTRODES COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2013-01-31 WO claimed
US-5290911-A Forming polymers by catalytic oxidative coupling RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT (JP) 1994-03-01 US claimed
US-12606675-B2 Sulfur-containing polymer, method for producing same, and sulfur-containing polymer composition NIPPON SHOKUBAI CO., LTD. (JP) 2026-04-21 US disclosed
WO-2024057020-A1 ANTI-VIRAL COMPOUNDS Infex Therapeutics Limited (GB) 2024-03-21 WO disclosed
WO-2023223670-A1 POLYMER AND RESIN COMPOSITION FOR OPTICAL LENS 日産化学株式会社 2023-11-23 WO disclosed
US-20230357507-A1 SULFUR-CONTAINING POLYMER, METHOD FOR PRODUCING SAME, AND SULFUR-CONTAINING POLYMER COMPOSITION NIPPON SHOKUBAI CO., LTD. (JP) 2023-11-09 US disclosed
EP-4220242-A1 SULFUR-CONTAINING POLYMER, METHOD FOR PRODUCING SAME, AND SULFUR-CONTAINING POLYMER COMPOSITION Nippon Shokubai Co., Ltd. (JP) 2023-08-02 EP disclosed
CN-116235081-A Sulfur-containing polymer, process for producing the same, and sulfur-containing polymer composition 株式会社日本触媒 2023-06-06 CN disclosed
US-11552266-B2 Electrodes for electronic devices comprising an organic semiconducting layer FLEXENABLE LIMITED (GB) 2023-01-10 US disclosed
US-5290911-A Forming polymers by catalytic oxidative coupling RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT (JP) 1994-03-01 US disclosed
US-5153305-A From diaryl disulfide; mild conditions using organometallic catalyst RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT (JP) 1992-10-06 US disclosed
US-4983720-A Process for preparing a polyarylene thioether IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1991-01-08 US disclosed
EP-0402481-A1 PRODUCTION OF POLYARYLENE THIOETHER RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT (JP) 1990-12-19 EP disclosed
US-4931542-A Process for preparing a polyarylene thioether IDEMITSU PETROCHEMICAL COMPANY, LIMITED (JP) 1990-06-05 US disclosed
EP-0281036-A2 A process for preparing a polyarylene thioether IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1988-09-07 EP disclosed
US-4523012-A INTERMEDIATES FOR PRODUCTION OF D,L-CYSTEINE AND DERIVATIVES DEGUSSA AKTIENGESELLSCHAFT (DE) 1985-06-11 US disclosed
US-4024272-A Tetracyclic compounds MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1977-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606675-B2 Sulfur-containing polymer, method for producing same, and sulfur-containing polymer composition UACA, SMC3, SMC2 ALDH1A1 1086/4885CYP1A1 2334/4885CYP1B1 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.